Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IP paclitaxel + oral S-1 + IV oxaliplatin for gastric cancer with peritoneal metastasis
KCT0004670Phase 2Completed
- Sponsor
- Chong Kun Dang
- Start
- Jun 2020
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, tegafur, oxaliplatin in gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, gastric cancer (GC), sponsored by Chong Kun Dang. Started Jun 2020; status: completed.
02
Drugs
paclitaxeltegafuroxaliplatin
03
Conditions
gastric adenocarcinomagastroesophageal junction adenocarcinomagastric cancer (GC)
Beyond the preview
Go deeper on KCT0004670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004670.